Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Growth Capital Partners (GCP) is a UK-based private equity firm that specializes in providing growth capital to small and medium-sized enterprises (SMEs), with a significant focus on the healthcare and pharmaceutical services sectors. The firm typically targets businesses with enterprise values between £25 million and £100 million, offering flexible equity solutions to support international expansion and strategic acquisitions. In the life sciences space, GCP has a track record of investing in specialized service providers, including medical communications agencies and clinical research organizations (CROs). Notable investments in the sector have included P2P, a healthcare communications agency, and The Clinical Trial Company (TCTC). The firm is known for its partnership-led approach, working closely with management teams to drive operational improvements and long-term value creation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Growth Capital Partners.